Smallpox vaccine adverse events among civilians--United States, February 25-March 3, 2003.
During the civilian smallpox vaccination program, CDC, the Food and Drug Administration, and state health departments are conducting surveillance for vaccine-associated adverse events. In the first stage of the program, active surveillance is being conducted for potentially life-threatening, moderate-to-severe, and other serious adverse events and for vaccinia transmission to contacts of vaccinees (Table). Nonserious events are reported through passive surveillance and are expected to be underreported. This report summarizes smallpox vaccine adverse events reported among civilians vaccinated as of February 28, 2003, and among contacts of vaccinees, received by CDC from the Vaccine Adverse Event Reporting System (VAERS) as of March 3.
D000293:Adolescent; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D015817:Eye Infections / Q000209:etiology; D005260:Female; D006282:Health Personnel; D006801:Humans; D008889:Military Personnel; D011159:Population Surveillance; D011634:Public Health; D012900:Smallpox Vaccine / Q000009:adverse effects*; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000009:adverse effects; D014615:Vaccinia / Q000453:epidemiology / Q000209:etiology*
D012900:Smallpox Vaccine